C4X Discovery Holdings PLC | Ownership
Companies that own C4X Discovery Holdings PLC
Baillie Gifford & Co.
2,933,061
6.3%
719,594
0%
07/31/2017
Legal & General Investment Management Ltd.
2,882,000
6.19%
1,000,000
0%
07/31/2017
Investec Wealth & Investment Ltd.
2,769,000
5.95%
0
0.02%
06/04/2018
Hargreave Hale Ltd.
2,541,000
5.46%
100,000
0.03%
09/18/2017
City Financial Investment Co. Ltd.
2,145,000
4.61%
0
0.26%
07/31/2017
Herald Investment Management Ltd.
1,500,000
3.22%
0
0.14%
07/31/2017
Polar Capital LLP
1,250,000
2.69%
0
0%
07/31/2018
Jarvis Investment Management Ltd.
1,039,000
2.23%
1,026,000
0.1%
06/04/2018
Rowan Dartington & Co. Ltd. (Broker)
969,000
2.08%
0
0.15%
06/04/2018
United Nations Joint Staff Pension Fund
911,000
1.96%
0
0.06%
06/04/2018
| Address |
Manchester One
Manchester Greater Manchester M1 3LD
United Kingdom
|
|
Employees
|
- |
| Website |
http://c4xdiscovery.com/ |
| Updated |
07/08/2019 |
| C4X Discovery Holdings Plc engages in the development of new technologies to improve the drug discovery process for novel small molecule therapies. Its software platforms consists of Taxonomy3, which utilizes a mathematical approach to discovery and validation of drug targets for the treatment of a variety of diseases; and Conformetrix, which determines the 3D shape of drug molecules from experimental in vitro data that enables the rapid design and discovery of novel and potent drugs for diseases with high unmet medical need across broad therapeutic areas. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. |
